Context Therapeutics Inc (CNTX): Grabbed a ton at $7

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	403
Posts	29690
Boards Moderated	0
Alias Born	08/27/2004

mkt_predictor

Re: None

Friday, 10/22/2021 11:44:52 AM

Friday, October 22, 2021 11:44:52 AM

Grabbed a ton at $7

My post is only my opinion, I recommend you always do your own DD! I am not a licensed broker or a professional by any means, so take what I say as entertainment value at best.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CNTX News

Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:22:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 11:34:25 AM
Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors • GlobeNewswire Inc. • 09/04/2024 11:30:47 AM
Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 08:17:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:07:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:18:30 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:15:17 PM
Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/24/2024 09:07:18 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/24/2024 08:55:48 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/12/2024 08:04:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 11:33:59 AM
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95 • GlobeNewswire Inc. • 07/10/2024 11:30:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 11:50:14 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:34:52 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/03/2024 04:15:21 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/31/2024 08:06:51 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/24/2024 08:15:19 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/24/2024 11:31:07 AM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/10/2024 08:00:06 PM
Context Therapeutics Reports First Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 05/08/2024 08:06:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:03:39 PM
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76 • GlobeNewswire Inc. • 05/02/2024 11:31:53 AM

More CNTX News

InvestorsHub NewsWire

FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM

Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM

PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM

North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM

One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM

Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover